The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment

E-ISSN： 1875-5992|11|8|756-761

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.11, Iss.8, 2011-10, pp. : 756-761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme

By Champ Colin Palmer Joshua Volek Jeff Werner-Wasik Maria Andrews David Evans James Glass Jon Kim Lyndon Shi Wenyin

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 125-131

Springer Publishing Company

Access to resources Recommend Favorite

Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study

By Bergenheim A. Capala Jacek Roslin Michael Henriksson Roger

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 287-293

Springer Publishing Company

Access to resources Recommend Favorite

Targeting cyclooxygenase-2 in human neoplasia - Rationale and promise

By Dannenberg A.J. Subbaramaiah K.

Cancer Cell, Vol. 4, Iss. 6, 2003-12 ,pp. : 431-436

Elsevier

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Pathway as Therapy for Glioblastoma

Current Cancer Therapy Reviews, Vol. 7, Iss. 1, 2011-02 ,pp. : 65-77

Bentham Science Publishers

Access to resources Recommend Favorite

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma

By Cruickshanks Nichola Zhang Ying Yuan Fang Pahuski Mary Gibert Myron Abounader Roger

Cancers, Vol. 9, Iss. 7, 2017-07 ,pp. : 87-87

MDPI

Access to resources Recommend Favorite